EDGAR Filing Documents for 0001104659-03-021713

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001104659-03-021713

Filing Date

2003-09-29

Accepted

2003-09-29 13:58:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	a03-3660_1sc13g.htm	SC 13G	62717
	Complete submission text file	0001104659-03-021713.txt		64744

Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139

Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500

GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SCIENCE PARK MELBOURN CAMBRIDGESHIRE U K SG8 6JJ

Business Address SCIENCE PARK MELBOURN CAMBRIDGESHIRE U K SG8 6JJ A1 011-44-1763-263233

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (Subject) CIK: 0001067386 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79252 | Film No.: 03914461
SIC: 8731 Services-Commercial Physical & Biological Research